Gilead Sciences, Inc

Headquarters location: 333 Lakeside Dr Foster City, CA 94404 Tel. 650-574-3000 Job offers, investor relations: www.gilead.com Email: corporate_communications@gilead.com Stock:

Gilead Sciences belongs to shareholder country     % source AXA 4 Barclays Plc 2.7 FMR Corp. (Fidelity Investments) 4.1 Massachusetts Financial Services 4.8 Oppenheimer Capital 3.4 Putnam LLC 2.2 Rowe Price Associates Inc. 3.4 TIAA-CREF 2.1 Wellington Management Co. 4.3	Brands name items photo compare the prices Gilead Sciences Ethishop Myogen Ethishop NeXstar Pharmaceuticals Ethishop Tenofovir Ethishop Viread Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF GILEAD_SCIENCES , group and subsidiaries [?] 1 Tax haven, secret bank account, shell companies: operates in 1 offshore financial center(s) 714 Top management: earns 714 times the median income in the United States (32000 US$/year) 1 Influence: 1 act(s) of direct corruption or lobbying 1 Advertising & marketing: 1 dubious practice(s) Full profile >>>
Relevance: business & market share year business source 2006 Gilead Sciences is the fourth-largest biotechnology group in the world. Les Echos World locations & Manufacturing country incentive : address & contact : production type source Gilead Irish Holdings, Ltd : Gilead Sciences Ltd : The map of tax haven, secret accounts and shell companies Gilead Sciences is managed by year name photo position; compensation source 2005Bischofberger, Norbert W Vice-president; salary: 1.07 million US$; stock-options: 19.99 million US$; 2005Martin, John C Chief Executive Officer; salary: 2.08 million US$; stock-options: 20.77 million US$; 2005Milligan, John F Chief Financial Officer; salary: 0.92 million US$; stock-options: 3.72 million US$; 2003Schultz, George H Director; Réseau Vol. 2002Denny, James Chairman; 2000Rumsfeld, Donald H Chairman; Highest paid executives in 2007 Advertising & marketing year dubious practice : image source 2005 Arguable partnership: Les essais cliniques du tenofovir ont été réalisés en partenariat avec Family Health International et financés par la Fondation Bill et Melinda Gates.: Le Monde D. Dubious practices in 2007

Made by year employees <> social impact : country source 2002 1250 2000 850 Layoff plans and labour conditions in 2007 Environmental impact year country : consequences source 2005 Nigeria : Essais cliniques du Tenofovir, un antiviral utilisé contre le sida, ont été suspendus en mars 2005, en raison de manquements éthiques graves. Le Monde D. Pollutions in 2007 Influence year purpose : intermediary/lobby : institution source 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. Influence in 2007 Financials year   sales income source 2003   0.87 -0.07   billion US$ 2002   0.47 0.07   billion US$ 2001   0.23 0.05   billion US$ 2000   0.2 -0.06   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Aig american group   AIG's Loss, Capital Needs Renew Doubts About Sullivan's Tenure - Friday 9 May 2008 at 08h30

Target   Target writes off 8.1% of its annualized credit card debt in March - Friday 2 May 2008 at 11h07

Dell computer   Dell confirms plan to cut 250 Irish jobs - Friday 2 May 2008 at 08h50

Henry   leatest profile of hery sy - Tuesday 29 April 2008 at 07h08

Dow jones   Wall Street Journal managing editor stepping down - Tuesday 22 April 2008 at 08h09

All comments